[German national disease management guidelines "diabetic neuropathy". Important implications on clinical practice].
Internistische Praxis-Gemeinschaft, Minchen Manfred.Haslbeck@lrz.uni-muenchen.de
Manfred
M
Haslbeck
Bernhard
B
Neundörfer
Stefan
S
Wilm
D000700:Analgesics / Q000627:therapeutic use; D000701:Analgesics, Opioid / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D003937:Diagnosis, Differential; D004185:Disability Evaluation; D006801:Humans; D008403:Mass Screening; D009460:Neurologic Examination; D010147:Pain Measurement / Q000187:drug effects; D012307:Risk Factors
D000700:Analgesics; D000701:Analgesics, Opioid; D000894:Anti-Inflammatory Agents, Non-Steroidal